Forbes April 17, 2024
According to the American Society of Health System Pharmacists, 323 drugs are currently experiencing shortages in the United States, the highest number the organization has seen since it began recording drug shortages in 2001. These include chemotherapies, ADHD medications, oxytocin and more. And the threat of shortages has a chance to be exacerbated further, at least in the short term, due to pending bipartisan legislation in both houses called the BIOSECURE Act,. If enacted, it might prevent American companies from working with key Chinese biotech contractors like WuXi AppTec, WuXi Biologics and MGI Tech. Stock prices have fallen significantly for these companies since the bill was introduced, and drug companies have warned investors that passage of the bill could have...
Today's Sponsors
Today's Sponsor